- Home
- GPCR vs FBIN Comparison
GPCR vs FBIN Comparison
Compare GPCR & FBIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GPCR | FBIN |
|---|---|---|
| Founded | 2016 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Building Products |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3B | 6.2B |
| IPO Year | 2023 | 2011 |
Fundamental Metrics
Financial Performance| Metric | GPCR | FBIN |
|---|---|---|
| Price | $63.04 | $54.45 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 11 |
| Target Price | ★ $103.09 | $61.40 |
| AVG Volume (30 Days) | 810.8K | ★ 3.2M |
| Earning Date | 05-29-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 1.91% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.47 |
| Revenue | N/A | ★ $4,463,200,000.00 |
| Revenue This Year | N/A | $4.01 |
| Revenue Next Year | N/A | $3.62 |
| P/E Ratio | ★ N/A | $22.06 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.24 | $44.04 |
| 52 Week High | $94.90 | $65.84 |
Technical Indicators
Market Signals| Indicator | GPCR | FBIN |
|---|---|---|
| Relative Strength Index (RSI) | 32.93 | 45.52 |
| Support Level | $60.42 | $48.86 |
| Resistance Level | $72.00 | $57.18 |
| Average True Range (ATR) | 3.56 | 2.48 |
| MACD | -1.49 | -0.50 |
| Stochastic Oscillator | 4.58 | 29.95 |
Price Performance
Historical ComparisonAbout GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.
About FBIN Fortune Brands Innovations Inc.
Fortune Brands Innovations is a leading home and security products company that has three reportable segments. The company's $2.6 billion water segment, led by the Moen brand, sells faucets, showers, and other plumbing fixtures; the $1.4 billion outdoors segment primarily sells entry doors under the Therma-Tru brand name and Fiberon-branded patio decking; and the $700 million security segment sells locks and other security devices under the Master Lock, SentrySafe, Yale, and August brand names.